Molecular Toxicology of Neuropathy Target Esterase

Anticholinesterase Pesticides: Metabolism, Neurotoxicity, and Epidemiology

Volumn , Issue , 2011, Pages 109-120

  Wu, Yi Jun ^a   Chang, Ping An ^b  

^a INSTITUTE OF ZOOLOGY   (China)

^b CHONGQING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Discovery of NTE to proposition of hypotheses mechanisms of OPIDN; Molecular biology of neuropathy target esterase; Molecular toxicology of neuropathy target esterase (NTE)

Indexed keywords

EID: 84885719743     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470640500.ch9     Document Type: Chapter

References (66)

1. Acierno, J. S., Jr., Kennedy, J. C., Falardeau, J. L., Leyne, M., Bromley, M. C., Colman, M. W., Sun, M., Bove, C., Ashworth, L. K., Chadwick, L. H., Schiripo, T., Ma, S., Goldin, E., Schiffmann, R., and Slaugenhaupt, S. A. (2001). A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2. Genomics 73(2):203-210.
2. Akassoglou, K., Malester, B., Xu, J., Tessarollo, L., Rosenbluth, J., and Chao, M. V. (2004). Brain-specific deletion of neuropathy target esterase/swiss cheese results in neurodegeneration. Proc Natl Acad Sci USA 101(14):5075-5080.
3. Atkins, J., and Glynn, P. (2000). Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase. J Biol Chem 275(32):24477-24483.
4. Atkins, J., Luthjens, L. H., Hom, M. L., and Glynn, P. (2002). Monomers of the catalytic domain of human neuropathy target esterase are active in the presence of phospholipid. Biochem J 361(1):119-123.
5. Barber, D., Correll, L., and Ehrich, M. (1999a). Comparison of two in vitro activation systems for protoxicant organophosphorous esterase inhibitors. Toxicol Sci 47(1):16-22.
6. Barber, D., Correll, L., and Ehrich, M. (1999b). Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J Toxicol Environ Health A 57(1):63-74.
7. Carrington, C. D., Fluke, D. J., and Abou-Donia, M. B. (1985). Target size of neurotoxic esterase and acetylcholinesterase as determined by radiation inactivation. Biochem J 231:789-792.
8. Chang, P. A., Chen, R., Wu, Y. J. (2005a). Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line. Mol Brain Res 141(1):30-38.
9. Chang, P. A., Wu, Y. J., Chen, R., Li, M., Li, W., and Qin, Q. L. (2005b). Inhibition of neuropathy target esterase expressing by antisense RNA does not affect neural differentiation in human neuroblastoma (SK-N-SH) cell line. Mol Cell Biochem 272(1-2):47-54.
10. Chang, P. A., Liu, Ch. Y., Chen, R., and Wu, Y. J. (2006). Effect of over-expression of neuropathy target esterase on mammalian cell proliferation. Cell Prolif 39(5):429-440.
11. Chang, P. A., Long, D. X., and Wu, Y. J. (2007). Molecular cloning and expression of the C-terminal domain of mouse NTE-related esterase. Mol Cell Biochem 306(1-2):25-32.
12. Chen, R., Yang, L., Yao, Z., Liu, C. Y., Li, X. H., Li, Q., Liu, J., Chang, P. A., Li, W., and Wu, Y. J. (2005). Hunting for novel proteins in neuropathy target esterase regulatory domain with yeast two-hybrid system. Acta Zool Sin 51(5):840-844.
13. Chen, R., Chang, P. A., Long, D. X., Liu, C. Y., Yang, L., and Wu, Y. J. (2007a). G protein beta2 subunit interacts directly with neuropathy target esterase and regulates its activity. Int J Biochem Cell Biol 39(1):124-132.
14. Chen, R., Chang, P. A., Long, D. X., Yang, L., and Wu, Y. J. (2007b). Down-regulation of neuropathy target esterase by protein kinase C activation with PMA stimulation. Mol Cell Biochem 302:179-185.
15. De Bleecker, J. L. (2006). Intermediate syndrome in organophosphate poisoning. In: Ramesh C. Gupta (Ed.), Toxicology of Organophosphate and Carbamate Compounds, pp. 371-380. Amsterdam: Academic Press/Elsevier.
16. Dremier, S., Kopperud, R., Doskeland, S. O., Dumont, J. E., and Maenhaut, C. (2003). Search for new cyclic AMP-binding proteins. FEBS Lett 546(1):103-107.
17. Ehrich, M. (1995). Using neuroblastoma cell lines to address differential specificity to organophosphates. Clin Exp Pharmacol Physiol 22(4):291-292.
18. Ehrich, M., and Veronesi, B. (1995). Esterase comparison in neuroblastoma cells of human and rodent origin. Clin Exp Pharmacol Physiol 22(5): 385-386.
19. Ehrich, M., Correll, L., and Veronesi, B. (1994). Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Neurotoxicology 15(2):309-313.
20. Ehrich, M., Correll, L., and Veronesi, B. (1997). Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundam Appl Toxicol 38(1):55-63.
21. Gallazzini, M., Ferraris, J. D., Kunin, M., Morris, R. G., and Burg, M. B. (2006). Neuropathy target esterase catalyzes osmoprotective renal synthesis of glycerophosphocholine in response to high NaCl. Proc Natl Acad Sci USA 103(41):15260-15265.
22. Glynn, P. (2000). Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog Neurobiol 61(1):61-74.
23. Glynn, P. (2003). NTE: one target protein for different toxic syndromes with distinct mechanisms? Bioessays 25(8):742-745.
24. Glynn, P. (2005). Neuropathy target esterase and phospholipid deacylation. Biochim Biophys Acta 1736(2):87-93.
25. Glynn, P. (2006). A mechanism for organophosphate-induced delayed neuropathy. Toxicol Lett 162(1):94-97.
26. Glynn, P. (2007). Axonal degeneration and neuropathy target esterase. Arh Hig Rada Toksikol 58(3):355-358.
27. Glynn, P., Read, D. J., Guo, R., Wylie, S., and Johnson, M. K. (1994). Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. Biochem J 301(2):551-556.
28. Glynn, P., Holton, J. L., Nolan, C. C., Read, D. J., Brown, L., Hubbard, A., and Cavanagh, J. B. (1998). Neuropathy target esterase: immunolocalization to neuronal cell bodies and axons. Neuroscience 83(1):295-302.
29. Gupta, R. C. (2006). Classification and uses of organophosphates and carbamates. In: Ramesh C. Gupta (Ed.), Toxicology of Organophosphate and Carbamate Compounds, pp. 5-24. Amsterdam: Academic Press/Elsevier.
30. Hou, W. Y., Long, D. X., Wang, H. P., Wang, Q., and Wu, Y. J. (2008). The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate induced delayed neurotoxicity in hens. Toxicology 252(1-3):56-63.
31. Ito, K., Adachi, S., Iwakami, R., Yasuda, H., Muto, Y., Seki, N., and Okano, Y. (2001). N-Terminally extended human ubiquitinconjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8. Eur J Biochem 268(9):2725-2732.
32. Jackowski, S., and Fagone, P. (2005). CTP: phosphocholine cytidylyltransferase: paving the way from gene to membrane. J Biol Chem 280(2):853-856.
33. Johnson, M. K. (1969). The delayed neurotoxic action of some organophorous compounds. Identification of the phosphorylation site as an esterase. Biochem J 114(4):711-717.
34. Johnson, M. K. (1974). The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J Neurochem 23(4):785-789.
35. Johnson, M. K. (1993). Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters. Chem Biol Interact 87(1-3):339-346.
36. Kamijima, M., and Casida, J. E. (1999). Localization of [3H] octylphosphonyl-labeled neuropathy target esterase by chicken nervous tissue autoradiography. Neurosci Lett. 273(2):101-104.
37. Kretzschmar, D., Hasan, G., Sharma, S., Heisenberg, M., and Benzer, S. (1997). The Swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci 17(19):7425-7432.
38. Kropp, T. J., Glynn, P., and Richardson, R. J. (2004). The mipafoxinhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 43(12):3716-3722.
39. Li, Y., Dinsdale, D., and Glynn, P. (2003). Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in mammalian cells. J Biol Chem 278(10):8820-8825.
40. Li, Z., Szurek, P. F., Jiang, C., Pao, A., Bundy, B., Le, W. D., Bradley, A., and Yu, Y. E. (2005). Neuronal differentiation of NTE-deficient embryonic stem cells. Biochem Biophys Res Commun 330(4):1103-1109.
41. Long, D. X., Chang, P. A., Liang, Y. J., Yang, L., and Wu, Y. J. (2009). Degradation of neuropathy target esterase by macroautophagic lysosomal pathway. Life Sci 84(3-4):89-96.
42. Lotti, M., and Moretto, A. (1993). The search for the physiological functions of NTE: is NTE a receptor? Chem Biol Interact 87(1-3):407-416.
43. Lush, M. J., Li, Y., Read, D. J., Willis, A. C., and Glynn, P. (1998). Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J 332(1):1-4.
44. Milatović, D., and Johnson, M. K. (1993). Reactivation of phosphorodiamidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride. Chem Biol Interact 87(1-3):425-430.
45. Moser, M., Stempfl, T., Li, Y., Glynn, P., Büttner, R., and Kretzschmar, D. (2000). Cloning and expression of the murine sws/NTE gene. Mech Dev 90(2):279-282.
46. Moser, M., Li, Y., Vaupel, K., Kretzschmar, D., Kluge, R., Glynn, P., and Buettner, R. (2004). Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol 24(4):1667-1679.
47. Mühlig-Versen, M., da Cruz, A. B., Tschäpe, J. A., Moser, M., Büttner, R., Athenstaedt, K., Glynn, P., and Kretzschmar, D. (2005). Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and REFERENCES 119 neuronal and glial death in adult Drosophila. J Neurosci 25(11):2865-2873.
48. Murray, J. P., and McMaster, C. R. (2005). Nte1p-mediated deacylation of phosphatidylcholine functionally interacts with Sec14p. J Biol Chem 280(9):8544-8552.
49. Nostrandt, A. C., and Ehrich,M. (1992). Development of a model cell culture system in which to study early effects of neuropathy-inducing organophosphorus esters. Toxicol Lett 60(1):107-114.
50. Nostrandt, A. C., and Ehrich, M. (1993). Modification of mipafoxinduced inhibition of neuropathy target esterase in neuroblastoma cells of human origin. Toxicol Appl Pharmacol 121(1):36-42.
51. Pope, C. N., and Padilla, S. (1989). Modulation of neurotoxic esterase activity in vitro by phospholipids. Toxicol Appl Pharmacol 97(2):272-278.
52. Quistad, G. B., and Casida, J. E. (2004). Lysophospholipase inhibition by organophosphorus toxicants. Toxicol Appl Pharmacol 196(3):319-326.
53. Quistad, G. B., Barlow, C.,Winrow, C. J., Sparks, S. E., and Casida, J. E. (2003). Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc Natl Acad Sci USA 100(13):7983-7987.
54. Rainier, S., Bui, M., Mark, E., Thomas, D., Tokarz, D., Ming, L., Delaney, C., Richardson, R. J., Albers, J. W., Matsunami, N., Stevens, J., Coon, H., Leppert, M., and Fink, J. K. (2008). Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 82(3):780-785.
55. Richardson, R. J. (1995). Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 44(2):135-165.
56. Senanayake, N., and Karalliedde, L. (1987). Neurotoxic effects of organophosphorus insecticides. an intermediate syndrome. N Engl J Med 316(13):761-763.
57. Thomas, T. C., Szekacs, A., Rojas, S., Hammock, B. D., Wilson, B. W., and Mcnamee, M. G. (1990). Characterization of neuropathy target esterase using trifluoromethyl ketones. Biochem Pharmacol 40(12):2587-2596.
58. van Tienhoven, M., Atkins, J., Li, Y., and Glynn, P. (2002). Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J Biol Chem 277(23):20942-20948.
59. Veronesi, B., and Ehrich, M. (1993). Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol Appl Pharmacol 120(2): 240-246.
60. Veronesi, B., Ehrich, M., Blusztajn, J. K., Oortgiesen, M., and Durham, H. (1997). Cell culture models of interspecies selectivity to organophosphorous insecticides. Neurotoxicology 18(1):283-297.
61. Wijeyesakere, S. J., Richardson, R. J., and Stuckey, J. A. (2007). Modeling the tertiary structure of the patatin domain of neuropathy target esterase. Protein J 26(3):165-172.
62. Williams, D. G. (1983). Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. Biochem J 209(3):817-829.
63. Williams, D. G., and Johnson, M. K. (1981). Gel-electrophoretic identification of hen brain neurotoxic esterase, labelled with tritiated di-isopropyl phosphorofluoridate. Biochem J 199(2): 323-333.
64. Wilson, P. A., Gardner, S. D., Lambie, N. M., Commans, S. A., and Crowther, D. J. (2006). Characterization of the human patatin-like phospholipase family. J Lipid Res 47(9): 1940-1949.
65. Winrow, C. J., Hemming, M. L., Allen, D. M., Quistad, G. B., Casida, J. E., and Barlow, C. (2003). Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nature Genet 33(4):477-485.
66. Zaccheo, O., Dinsdale, D., Meacock, P. A., and Glynn, P. (2004). Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem 279(23):24024-24033.